Literature DB >> 9713914

Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).

J C Lefèvre1, J P Lépargneur.   

Abstract

BACKGROUND AND OBJECTIVES: We recently reported the first isolation of a tetracycline-resistant Chlamydia trachomatis strain in Toulouse from a woman treated with tetracycline. To characterize this isolate, its in vitro susceptibility was compared with those of 34 other C. trachomatis isolates recovered in Toulouse. STUDY
DESIGN: The susceptibilities of C. trachomatis strains were determined in terms of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) using McCoy cells in 96-well microdilution plates, with an inoculum of 5.10(3) to 1.10(4) inclusion-forming units/ml. The antimicrobial agents tested were tetracycline, azithromycin, erythromycin, ofloxacin, and pristinamycin.
RESULTS: No difference was observed between the MICs and MBCs except for the tetracycline. Tetracycline-resistant strain MIC and MBC were > 64 micrograms/ml, although < 1% of the bacterial population showed resistance. For the other isolates, the MIC of tetracycline was < or = 0.25 microgram/ml. The antibiotics other than tetracycline were active in vitro against all strains.
CONCLUSIONS: These results show that the tetracycline resistance observed in Toulouse differs from the "heterotypic resistance" described previously in the United States in multiresistant C. trachomatis isolates. They confirm that the resistance we observed may be a new phenomenon.

Entities:  

Mesh:

Year:  1998        PMID: 9713914     DOI: 10.1097/00007435-199808000-00005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

Review 1.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 2.  The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection.

Authors:  P Horner
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

3.  In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.

Authors:  Suncanica Ljubin-Sternak; Tomislav Mestrovic; Tatjana Vilibic-Cavlek; Gordana Mlinaric-Galinovic; Mario Sviben; Alemka Markotic; Visnja Skerk
Journal:  Folia Microbiol (Praha)       Date:  2012-12-29       Impact factor: 2.099

4.  Growth and development of tetracycline-resistant Chlamydia suis.

Authors:  J Lenart; A A Andersen; D D Rockey
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene.

Authors:  Jae Dugan; Daniel D Rockey; Loren Jones; Arthur A Andersen
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  The laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  Max A Chernesky
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

7.  Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection.

Authors:  Man-Li Qi; Yuan-Li Guo; Qian-Qiu Wang; Xiang-Sheng Chen; Jian-De Han; Xiao-Hong Su; Wen-Hui Lun; Hao Cheng; Jin-Hua Xu; Hong-Qing Tian; Li Chen; Zhi-Yuan Yao; Wen-Li Feng; Juan Jiang; Ping-Yu Zhou; Xian-Biao Zou; Hong-Hui Xu; Wei-Min Shi; Jun Liu; Lin Zhu; Quan-Zhong Liu
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

8.  Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS).

Authors:  Lenka A Vodstrcil; Thusitha W T Rupasinghe; Fabian Y S Kong; Dedreia Tull; Karen Worthington; Marcus Y Chen; Wilhelmina M Huston; Peter Timms; Malcolm J McConville; Christopher K Fairley; Catriona S Bradshaw; Sepehr N Tabrizi; Jane S Hocking
Journal:  PLoS One       Date:  2017-05-12       Impact factor: 3.240

Review 9.  Treatment challenges for urogenital and anorectal Chlamydia trachomatis.

Authors:  Fabian Yuh Shiong Kong; Jane Simone Hocking
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

Review 10.  On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.

Authors:  R Matthew Chico; Berkin B Hack; Melanie J Newport; Enesia Ngulube; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-06       Impact factor: 5.091

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.